Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11485710 Heterocyclic amides as kinase inhibitors

Patent 11485710 was granted and assigned to GlaxoSmithKline on November, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

GlaxoSmithKline

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114857100

Patent Inventor Names

Philip Anthony Harris0

Nicolas Eric Faucher0

Nicolas S. George0

Patrick M. Eidam0

Alain Claude-Marie Daugan0

Bryan W. King0

Clark A. Sehon0

David Duff Wisnoski0

...

Date of Patent

November 1, 2022

Patent Application Number

171564780

Date Filed

January 22, 2021

Patent Citations

‌

US Patent 10590085 Heterocyclic amides as kinase inhibitors

Patent Primary Examiner

‌

Samantha L Shterengarts

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11485710 Heterocyclic amides as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API